24 August 2009 | A late stage bowel cancer drug has again failed to win a public subsidy following another rejection by the Pharmaceutical Benefits Advisory Committee (PBAC).
24 April 2009 | The Government has rejected a fifth bid to have a late-stage bowel cancer medication subsidised on the PBS.